Tag: growth

ROCKVILLE, Md., July 22, 2025 (GLOBE NEWSWIRE) -- Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN), a biopharmaceutical company focused on developing and commercializing products for the treatment of central nervous system (CNS) diseases, today announced that the Company expects to report financial and business results for the second quarter of 2025 after the market closes on Tuesday, August 5, 2025.

FORT WORTH, Texas, July 22, 2025 (GLOBE NEWSWIRE) -- RANGE RESOURCES CORPORATION (NYSE: RRC) today announced its second quarter 2025 financial results.

EMERYVILLE, Calif., July 22, 2025 (GLOBE NEWSWIRE) -- Grocery Outlet Holding Corp. (NASDAQ: GO) (“Grocery Outlet”) today announced that its financial results for the second quarter of fiscal 2025 will be released after the market close on Tuesday, August 5, 2025. The company will host a conference call at 4:30pm ET (1:30pm PT) to discuss the results.

ST. PETERSBURG, Fla., July 22, 2025 (GLOBE NEWSWIRE) -- Superior Group of Companies, Inc. (NASDAQ: SGC) (the “Company”) today announced that it will release the results of its operations for the second quarter 2025 after the market close on Tuesday, August 5, 2025. Michael Benstock, Chairman, President and Chief Executive Officer, and Mike Koempel, Chief Financial Officer, will host a teleconference at 5:00 pm Eastern Time that day to discuss the Company’s results.

BOSTON, July 22, 2025 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a global commercial-stage biopharmaceutical company focused on transforming the lives of patients living with rare neuroendocrine diseases, today announced that it will host a live conference call and webcast at 8:00 a.m. ET on Tuesday, August 5, 2025 to report its second quarter 2025 financial results and provide a corporate update.

BOCA RATON, FL, July 22, 2025 (GLOBE NEWSWIRE) -- DeFi Development Corp. (Nasdaq: DFDV) (the “Company”), the first US public company with a treasury strategy built to accumulate and compound Solana (“SOL”), today announced it will publish its second quarter 2025 financial results and business outlook on its investor relations website at https://defidevcorp.com/investor?tab=Earnings on Tuesday, August 12, 2025, at approximately 4:00 p.m. Eastern Time.

[220+ Pages Latest Report] According to a market research study published by Custom Market Insights, the demand analysis of Global Plant Tissue Culture Market size & share revenue was valued at approximately USD 525.98 Million in 2024 and is expected to reach USD 570.61 Million in 2025 and is expected to reach around USD 1,205.94 Million by 2034, at a CAGR of 8.67% between 2025 and 2034. The key market players listed in the report with their sales, revenues and strategies are Phytoclone Inc., Melford Laboratories, Lifesible, Labland Biotech Private Limited, Knight Hollow Nursery, IribovSBW, HIMEDIA LABORATORIES, DP-Deroose Plants, Dark Heart Nursery, Caisson Laboratories, Inc., Booms Pharm, Alpha Laboratories, AgriStarts, AgriForest Bio-Technologies, 3 Rivers Biotech and others.

DURHAM, N.C., July 22, 2025 (GLOBE NEWSWIRE) -- Aspida Life Re Ltd (“Aspida Re”), a Bermuda-based life and annuity reinsurance company, announced the execution of its second reinsurance transaction in Japan, effective June 1, 2025. This milestone marks a significant step in Aspida Re’s ongoing strategy to expand its global footprint and deliver innovative reinsurance solutions to life and annuity insurance partners worldwide.